Subgroup | No. of studies | OR | 95%CI | p | I2 (%) | Effect-model |
---|---|---|---|---|---|---|
One-year | ||||||
MACCE | 6 | 1.35 | 0.73–2.49 | 0.34 | 0 | Fixed |
Death | 5 | 1.32 | 0.47–3.70 | 0.59 | 0 | Fixed |
Myocardial infarction | 6 | 1.31 | 0.64–2.70 | 0.46 | 0 | Fixed |
Repeat revascularization | 6 | 3.28 | 1.62–6.64 |  < 0.001 | 0 | Fixed |
Stroke | 2 | 3.73 | 0.60–23.02 | 0.16 | 0 | Fixed |
Within one to five year | ||||||
MACCE | 4 | 1.25 | 0.53–2.97 | 0.61 | 64 | Random |
Neurologic event | 2 | 0.29 | 0.07–1.15 | 0.08 | 22 | Fixed |
Death | 3 | 1.90 | 0.66–5.48 | 0.24 | 0 | Fixed |
Myocardial infarction | 3 | 1.18 | 0.44–3.14 | 0.74 | 33 | Fixed |
Repeat revascularization | 4 | 2.84 | 1.64–4.92 |  < 0.001 | 0 | Fixed |
Five-year | ||||||
MACCE | 3 | 0.93 | 0.61–1.41 | 0.72 | 25 | Fixed |
Death | 3 | 0.35 | 0.18–0.69 | 0.002 | 15 | Fixed |
Myocardial infarction | 3 | 0.83 | 0.34–2.04 | 0.68 | 0 | Fixed |
Repeat revascularization | 4 | 1.05 | 0.71–1.53 | 0.82 | 7 | Fixed |
Stroke | 2 | 0.57 | 0.16–2.01 | 0.39 | 0 | Fixed |